Based on a Cardiac Safety Research Consortium Think Tank held in October 2017 on “Detection, Assessment, and Risk Mitigation of Cardiac Safety Signals in Oncology Drug Development, this publication discusses emerging cardio-oncology nuances and the latest regulatory thinking on ways to manage risks.
Error - something went wrong!
Placebo Response Reduction
WCG has developed and validated the industry-leading Placebo Response Reduction training program.
Request a Genetics in Clinical Trials training sessionWhat You'll Learn
Most Recent Flipbooks
No Longer an Afterthought - A Call for Greater Diversity and Inclusion in Clinical Trials
Q&A - Negotiating Clinical Trial Agreements for Sites
Q&A - Frequently Asked Research Billing Compliance Questions
Relieving the Safety Reporting Burden on Sites: 4 Takeaways
The BNSS Scale In Translation: A Review of Psychometric Properties and Beyond
Translational Research Key to Meeting Real-World Needs During Pandemic
Using Predictable and Efficient Data to Take the Risk Out of Site Selection
Article - Coverage Analysis for Non-COVID Trials During the Pandemic
What is a Coverage Analysis and Why are They Important for Research Programs?
Making Coverage Analysis Determinations for Outside-the-Box Situations
Design and Conduct of Confirmatory Chronic Pain Clinical Trials
WCG Benchmark Analysis 2020
Sites Plan to Continue Using Telemedicine Solutions After Pandemic, Survey Says
WCG Remote Assessments
IRB Experts Offer Advice for Changing Research Landscape
Timely, Targeted Interventions: Infographic
WCG ThreeWire- Remote Clinical Research Coordinator Service
WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies
Changes to Research Made in Response to COVID-19
Basket Clinical Trial Designs The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct